Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added the 2026 NEJM article 'Nivolumab for Resected Stage III or IV Melanoma at 9 Years' to Publications and removed the 2025 ahead-of-print citation.
    Difference
    0.0%
    Check dated 2026-02-21T05:56:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; this appears to be a minor version update with no visible changes to page content or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-14T05:13:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-07T04:59:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added related topic references for Melanoma and MedlinePlus Genetics on the page. These links appear as auxiliary educational references and do not change the study details or user actions.
    Difference
    0.1%
    Check dated 2026-01-31T02:01:16.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added UI elements and metadata: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-23T22:40:23.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Minor versioning updates were made: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no impact on trial details or how to use the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:41:27.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.